Market-Moving News for July 29th
Market-Moving News for July 29th
7月29日市场资讯
LGVN: 49% | Longeveron Announced Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B In Mild Alzheimer's Disease; Study Meets Its Key Objectives To Advance Data Supporting Favorable Benefit/Risk Profile
Longeveron宣布Lomecel-b用于轻度阿尔茨海默病的CLEAR MIND II期临床试验结果,研究已达到其推进有利益/风险比支持的关键目标
PHG: 11% | Koninklijke Philips Q2 2024 Adj EPS €0.30 Beats €0.25 Estimate, Sales €4.462B Beat €4.430B Estimate
皇家飞利浦第二季度2024年调整后每股收益0.30欧元,超过0.25欧元的估值,销售额为44.62亿欧元,超过44.3亿欧元的估值
LIPO: 204% | Lipella Pharmaceuticals Commences Phase 2a Trial For LP-310 In Oral Lichen Planus, Enrolls First Patients
Lipella药品开始进行LP-310用于口腔扁平苔藓的IIa期试验,已招募第一批患者